995 resultados para Leishmaniasis (Viannia)
Resumo:
Visceral leishmaniasis is a multisystemic zoonotic disease that can manifest with several symptoms, including neurological disorders. To investigate the pathogenesis of brain alterations occurring during visceral leishmaniasis infection, the expression of the cytokines IL-1β, IL-6, IL-10, IL-12p40, IFN-γ, TGF-β and TNF-α and their correlations with peripheral parasite load were evaluated in the brains of dogs naturally infected with Leishmania infantum. IL-1β, IFN-γ and TNF-α were noticeably up-regulated, and IL-10, TGF-β and IL-12p40 were down-regulated in the brains of infected dogs. Expression levels did not correlate with parasite load suggestive that the brain alterations are due to the host's immune response regardless of the phase of the disease. These data indicate the presence of a pro-inflammatory status in the nervous milieu of dogs with visceral leishmaniasis especially because IL-1β and TNF-α are considered key factors for the initiation, maintenance and persistence of inflammation. © 2012 Elsevier B.V.
Resumo:
The leishmaniasis is a spectral disease caused by the protozoan Leishmania spp., which threatens millions of people worldwide. Current treatments exhibit high toxicity, and there is no vaccine available. The need for new lead compounds with leishmanicidal activity is urgent. Considering that many lead leishmanicidal compounds contain a quinoidal scaffold and the thiazole heterocyclic ring is found in a number of antimicrobial drugs, we proposed a hybridization approach to generate a diverse set of semi-synthetic heterocycles with antileishmanial activity. We found that almost all synthesized compounds demonstrated potent activity against promastigotes of Leishmania (Viannia) braziliensis and reduced the survival index of Leishmania amastigotes in mammalian macrophages. Furthermore, the compounds were not cytotoxic to macrophages at fivefold higher concentrations than the EC50 for promastigotes. All molecules fulfilled Lipinski's Rule of Five, which predicts efficient orally absorption and permeation through biological membranes, the in silico pharmacokinetic profile confirmed these characteristics. The potent and selective activity of semi-synthetic naphthothiazoles against promastigotes and amastigotes reveals that the 2-amino-naphthothiazole ring may represent a scaffold for the design of compounds with leishmanicidal properties and encourage the development of drug formulation and new compounds for further studies in vivo. © 2013 John Wiley & Sons A/S.
Resumo:
The antileishmanial and immunomodulatory effects of propolis collected in Botucatu, São Paulo State, Brazil, were evaluated in Leishmania (Viannia) braziliensis experimental infection. The antileishmanial effect of propolis on promastigote forms was verified by reducing growth and by promoting morphologic alterations observed by scanning electron microscopy. In in vitro immunomodulatory assays, macrophages were pretreated with propolis and then infected with L. (V.) braziliensis. In vivo, supernatants from liver cells and peritoneal exudate of BALB/c mice pretreated with propolis and infected with Leishmania (107/mL promastigotes) were collected, and TNF- α and IL-12 were measured by ELISA. Macrophages incubated with propolis showed a significant increase in interiorization and further killing of parasites. An increased TNF- α production was seen in mice pretreated with propolis, whereas IL-12 was downregulated during the infection. In conclusion, Brazilian propolis showed a direct action on the parasite and displayed immunomodulatory effects on murine macrophages, even though the parasite has been reported to affect the activation pathways of the cell. The observed effects could be associated with the presence of phenolic compounds (flavonoids, aromatic acids, and benzopyranes), di- and triterpenes, and essential oils found in our propolis sample. © 2013 Suelen Santos da Silva et al.
Resumo:
In Brazil, the rates of mother-to-child-transmission (MTCT) of human immunodeficiency virus (HIV) decreased from 20% to 1-2% in some regions. However, the country contains 90% of individuals infected with visceral leishmaniasis (VL) in Latin America, and the west region of São Paulo state faces an alarming expansion of the disease. We describe the epidemiological aspects of the expanding infection of VL and a case report of an HIV-VL-co-infected child from the west region of São Paulo state. The patient was an AIDS-C3 with low levels of CD4, high viral load, severe diarrhea, oral and perineal candidiasis, severe thrombocytopenia, and protein-caloric malnourishment. She evolved with sepsis, renal and cardiac failure. An rK rapid diagnosis test, indirect fluorescent antibody test (IFAT), and bone marrow aspirate were performed for VL. Her symptoms improved significantly after liposomal amphotericin B administration. From the 45 municipalities that compose the Regional Health Department of Presidente Prudente, Lutzomyia longipalpis vectors were found in 58% of them. VL infected dogs were found in 33% of those municipalities, infected dogs and humans were found in 29%, 20% are starting and 33% of the municipalities are preparing VL investigation. It is likely, in this patient, that VL advanced the clinical progression of the HIV disease and the development of AIDS severity. Supported by favorable conditions, the region becomes a new frontier of VL in Brazil. © 2013.
Resumo:
This study investigated the immunotherapeutic potential of the protein aggregate magnesium-ammonium phospholinoleate-palmitoleate anhydride immuno-modulator (P-MAPA) on canine visceral leishmaniasis. Twenty mongrel dogs presenting clinical symptoms compatible with leishmaniasis and diagnosis confirmed by the detection of anti-leishmania antibodies were studied. Ten dogs received 15 doses of the immunomodulator (2.0mg/kg) intramuscularly, and 10 received saline as a placebo. Skin and peripheral blood samples were collected following administration of the immunomodulator. The groups were followed to observe for clinical signals of remission; parasite load in the skin biopsies using real-time PCR, the cytokines IL-2, IL-10 and IFN-γ in the supernatant of peripheral blood mononuclear cells stimulated in vitro with either total promastigote antigen or phytohemagglutinin measured by capture ELISA, and changes in CD4+ and CD8+ T cell subpopulations evaluated by flow cytometry. Comparison between the groups showed that treatment with the immunomodulator promoted improvement in clinical signs and a significant reduction in parasite load in the skin. In peripheral blood mononuclear cell cultures, supernatants showed a decrease in IL-10 levels and an increase in IL-2 and IFN-γ. An increase in CD8+ T cells was observed in peripheral blood. In addition, the in vitro leishmanicidal action of P-MAPA was investigated using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and no leishmanicidal activity was detected. These findings suggest that P-MAPA has potential as an immunotherapeutic drug in canine visceral leishmaniasis, since it assists in reestablishing partial immunocompetence of infected dogs. © 2013 Elsevier B.V.
Resumo:
The aim of the present study was to test the hypothesis that oxidative stress and alteration of oxidative metabolism and apoptosis of neutrophils in dogs vary with the stage of leishmaniasis and to determine the contribution of uremia to such alterations. Dogs with leishmaniasis were classified into two stages: moderate (Leish II, n = 20) or very severe (i.e. with concurrent uremia; Leish IV, n = 20) according to the LeishVet Consensus. The two leishmaniasis groups were compared with uremic dogs without leishmaniasis (Uremic, n = 10) and to healthy dogs (Control, n = 30). To determine oxidative stress, total antioxidant/oxidant capacity, lipid peroxidation, total glutathione and the plasma antioxidants albumin, uric acid and bilirubin were quantified. Superoxide production was determined using the hydroethidine probe and viability and apoptosis were measured using annexin V-PE by capillary flow cytometry. Oxidative stress was present in both uremia and leishmaniasis with reduced total antioxidant capacity and was associated with increased induced production of superoxide and apoptosis. The greatest amount of oxidants was observed in animals with moderate disease only. Neutrophils from uremic dogs with and without leishmaniasis had decreased viability and an increased apoptosis rate in addition to increased lipid peroxidation. In conclusion, oxidative stress occurs in both stages of leishmaniasis with differences in intensity and levels of plasma markers; however, uremia does contribute to the decreased spontaneous viability of neutrophils in dogs in the final stage of the disease. © 2013 Elsevier Ltd. All rights reserved.
Resumo:
Development of vaccines against canine visceral leishmaniasis (CVL) may provide a prophylactic barrier, but antibody response detected by standard diagnostic techniques may not separate vaccinated from naturally infected dogs. Moreover, anti-Leishmania antibody levels in vaccinated dogs may be detectable for months. Accordingly, the aim of the present study was to comparatively evaluate an in-house ELISA with three serological tests officially adopted by the Brazilian Ministry of Health for the diagnosis of CVL in dogs vaccinated with Leishmune®. A total of 18 mongrel dogs were submitted to a complete protocol of the vaccine, monitored and evaluated in 5 times (T0-T4) up to 180 days after T0. Twenty-one days after the first dose (T1), 50% of the dogs were seropositive by the in-house ELISA and 5.5% by IFAT, while by the official ELISA and DPP® CVL rapid test all dogs tested negative. At time T2, 42 days after of the first dose, 100%, 83.3%, 11.1%, and 5.5% of the dogs were seropositive by the in-house ELISA, IFAT, official ELISA kit and the DPP® CVL rapid test, respectively. Ninety days after the first dose (T3), 100%, 83.3%, 72.2% and 33.3% of the dogs were seropositive by the in-house ELISA, official ELISA kit, IFAT, and the DPP® CVL rapid test, respectively. Finally, at time T4, 88.8%, 33.3%, 11.1% and 5.5% of the dogs were seropositive by the in-house ELISA, official ELISA kit, DPP® CVL rapid test and IFAT, respectively. In conclusion, dogs vaccinated with Leishmune® cross-react by an in-house ELISA and by the three official Brazilian serological tests for the diagnosis of canine visceral leishmaniasis up to six months after the first vaccine dose, and may be mistakenly diagnosed and removed. © 2013 Elsevier B.V.
Resumo:
The number of visceral leishmaniasis (VL) cases has increased over the past 10 years in Brazil, especially in the North and Northeast regions of the country. The aim of this study was to evaluate the urbanisation of VL vectors in Barcarena, Pará, an area in northern Brazil where VL is endemic. Sandflies were captured using Centers for Disease Control (CDC) light traps along an urban-rural gradient. The CDC traps were installed inside hen houses at a height of 150 cm. A total of 5,089 sandflies were collected and 11 species were identified. The predominant species was Lutzomyia longipalpis (rate of 95.15%), which suggests its participation in the transmission of VL. A total of 1,451 Lu. longipalpis females were dissected and no Leishmania infections were detected. Most of the sandflies were captured at the border of a forest (88.25%) and no flies were captured in the urban area, which suggests that transmission is still restricted to rural sites. However, the fact that a specimen was collected in an intermediate area indicates that urbanisation is a real possibility and that vector monitoring is important.
Resumo:
A leishmaniose tegumentar americana (LTA) é uma doença infecciosa, sendo uma zoonose de alta freqüência, endêmica na região Amazônica, transmitidas por flebotomíneos dos gêneros Psychodopygus e Lutzomyia. A Serra dos Carajás, situada no Sudeste do Pará, é amplamente explorada por empresas extrativistas e como resultado, concerniu-se que a LTA transformar-se-ia em um dos principais perigos de saúde para os trabalhadores, devido à prática de desmatamento e a construção de estradas de acesso e escoamento do minério. Assim, o objetivo deste estudo foi avaliar a infecção natural por Leishmania em flebotomíneos da região da Serra dos Carajás através da técnica PCR. As capturas de flebotomíneos foram realizadas em três diferentes ecótopos, Parque Zoobotânico de Quarentena, APA do Gelado e Tapirapé-Aquirí, com auxílio de armadilhas de luz tipo CDC e Shannon, durante o período noturno a partir do crepúsculo vespertino. Os flebotomíneos capturados foram identificados de acordo com Young & Duncan, 1994 e congelados em N2. Foram congelados 5.947 flebotomíneos, com 3.495 fêmeas, dentre estas, 550 espécimes foram testadas. Foi realizada as extrações de DNA das amostras utilizando-se SDS e KOAc e precipitação com etanol 96%. Foi realizada a PCR, amplificando-se a região do gene do mini-exon com os iniciadores S1629 (5’GGGAATTCAATAWAGTACAGAAACTG3’) e S1630 (5’GGGAAGCTTCTGTACTWTATTGGTA 3’). O DNA de Leishmania foi detectado em 36 (6,5%) flebotomíneos, sendo 34 do subgênero Viannia detectados em 30 Psychodopygus wellcomei/complexus, três Lutzomyia whitmani e um Lutzomyia shawi. Duas infecções por Leishmania amazonensis foram detectados em Psychodopygus wellcomei/complexus. Tapirapé – Aquirí, APA do Gelado e Parque Zoobotânico de Quarentena apresentaram altas taxas de infecção natural em flebotomíneos 6,54 %, 5,96 % e 7,92%, respectivamente. Psychodopygus wellcomei/complexus ainda apresenta destacado papel de vetor de Leishmania causadoras de LTA na região em questão. Estudos sobre o poder vetorial das espécies Lu. whitmani e Lu. shawi infectados naturalmente por Leishmania na Serra dos Carajás devem ser intensificados, verificando se essas espécies podem estar atuando no ciclo de transmissão da LTA na Serra dos Carajás. Estudos que melhor esclareçam a variação da prevalência de diferentes espécies de flebotomíneos e o conhecimento das taxas de infecção também devem ser intensificadas na região da Serra dos Carajás.
Resumo:
ABSTRACT: Leishmania (Leishmania) amazonensis has for some time been considered as the causative agent of two distinct forms of American cutaneous leishmaniasis (ACL): localized cutaneous leishmaniasis (LCL), and anergic diffuse cutaneous leishmaniasis (ADCL). Recently, a new intermediate form of disease, borderline disseminated cutaneous leishmaniasis (BDCL), was introduced into the clinical spectrum of ACL caused by this parasite, and in this paper we record the clinical, histopathological, and immunological features of eight more BDCL patients from Brazilian Amazonia, who acquired the disease in the Pará state, North Brazil. Seven of them had infections of one to two years' evolution and presented with primary skin lesions and the occurrence of metastases at periods varying from six to 12 months following appearance of the first lesion. Primary skin lesions ranged from 1-3 in number, and all had the aspect of an erythematous, infiltrated plaque, variously located on the head, arms or legs. There was lymphatic dissemination of infection, with lymph node enlargement in seven of the cases, and the delayed hypersensitivity skin-test (DTH) was negative in all eight patients prior to their treatment. After that, there was a conversion of DTH to positive in five cases re-examined. The major histopathological feature was a dermal mononuclear infiltration, with a predominance of heavily parasitized and vacuolated macrophages, together with lymphocytes and plasma cells. In one case, with similar histopathology, the patient had acquired his infection seven years previously and he presented with the largest number of disseminated cutaneous lesions. BDCL shows clinical and histopathological features which are different from those of both LCL and ADCL, and there is a good prognosis of cure which is generally not so in the case of frank ADCL.
Resumo:
A leishmaniose visceral canina (LVC) é reconhecida pelas características clínicas da doença e é altamente letal. A infecção, entretanto, pode ser totalmente assintomática em alguns cães soropositivos, o que tem levantado questão polêmica sobre a possibilidade desses animais, serem ou não uma fonte importante da infecção para o flebotomíneo, Lutzomyia longipalpis, o principal vetor da leishmaniose visceral americana (LVA). Neste estudo foram examinados 51 cães com LVC aguda, provenientes de área endêmica de LVA no Estado do Pará, Brasil, e a carga parasitária, formas amastigotas de, na pele, linfonodo poplíteo e vísceras (fígado e baço) foi comparada com a de nove cães assintomáticos soropositivos (IFAT-IgG). Fragmentos de biópsia desses tecidos obtidos post-mortem foram processados para análise através de imunohistoquímica, usando um anticorpo policlonal contra Leishmania sp. Os testes do Qui-quadrado (X2) e Mann Whitney foram usados para avaliar as médias da densidade de macrófagos infectados (p < 0,05). Os resultados mostraram que não houve diferença (p > 0,05) na densidade de macrófagos infectados da pele (10,7/mm2 x 15,5/mm2) e do linfonodo (6,3/mm2 x 8,3/mm2) entre cães assintomáticos e sintomáticos. Entretanto, a densidade de macrófagos infectados da víscera de cães sintomáticos (5,3/mm2) foi maior (p < 0,05) que a de cães assintomáticos (1,4/mm2). Estes resultados sugerem, fortemente, que cães naturalmente infectados por L. (L.) i. chagasi, assintomáticos ou sintomáticos, podem servir como fonte de infecção, principalmente, considerando-se que a densidade de macrófagos infectados da pele (10,7/mm2 x 15,5/mm2), local onde o flebotomíneo vetor Lu. longipalpis realiza a hematofagia, foi maior (p < 0,05) que as do linfonodo (6,3/mm2 x 8.3/mm2) e vísceras (1,4/mm2x 5,3/mm2).
Resumo:
A leishmaniose tegumentar (LT) encontra-se em expansão no Estado do Pará, Brasil. Juruti é um dos 143 municípios desse Estado e atualmente cenário de grandes transformações ambientais devido à mineração de bauxita, o que poderá influenciar o padrão de transmissão. Objetivo: Este estudo buscou elucidar aspectos epidemiológicos relevantes para o controle da LT em Juruti. Materiais e Métodos: A frequência de LT e o perfil dos pacientes no hospital municipal "Francisco Barros" foram determinados de janeiro a dezembro/2007. Espécies de flebotomíneos silvestres existentes no entorno de uma área de prospecção da bauxita foram também descritas, durante levantamento entomológico em janeiro/2008 (armadilha Shannon/18h às 20h/2 noites). Em 21 indivíduos, portadores de lesão cutânea suspeita de LT, biópsias de pele foram realizadas entre fevereiro e junho de 2007. Neste grupo procedeu-se ao diagnóstico parasitológico (esfregaço corado e cultura), molecular e teste intradérmico de Montenegro. Utilizaram-se sondas de DNA ribossomal (PCR-SSUrDNA) gênero específicas (S4, S12; S17, S18) e de G6PD, para distinguir o subgênero Viannia (ISVC, ISVA: ISVC, ISVG) e a espécie L. (V.) braziliensis (ISVC, ISVA; ISVC, ISVB). Resultados: No ano de 2007 foram confirmados 42 casos novos de LT, com média mensal inferior a quatro (3,5 ± 0,8), maior frequência em julho (11) e menor em junho e novembro (0). A maioria dos pacientes foi de homens (41/42, 98%) com menos de 20 anos (<10 anos: 30%; 10-20: 57%; 20-40: 12%). A maioria também residia em localidades rurais (33/42, 79%), incluindo áreas impactadas pela mineração (19/42, 45%), e exercia atividades de risco (28/42, 67%). Doze eram funcionários de empresas (29%). A análise molecular das 21 amostras identificou 12 resultados positivos para o gênero Leishmania (57%), sendo 11 (52%) parasitologicamente confirmados. A PCRG6PD identificou 75% das amostras como sendo L. (V.) braziliensis. As demais (3/12, 25%) não hibridizaram com os oligonucleotídeos da PCR-G6PD e, por isso, os produtos da reação de nested-PCR SSUrDNA foram clonados e sequenciados, confirmando que se tratavam de Leishmania (Viannia) sp. Apenas 9/12 (75%) casos confirmados pelos métodos parasitológico e/ou olecular tiveram reações de hipersensibilidade tardia em resposta ao antígeno de Montenegro, cujos diâmetros variaram de 7 a 40mm (16,3 ± 3,2). Capturaram-se 105 flebotomíneos de 13 espécies nas seguintes frequências: 1- Lutzomyia (Ps.) geniculata (23, 22%), 2- Lutzomyia (Ps.) paraensis (21, 20%), 3- Lutzomyia (Ps.) complexa (18, 17%), 4-Lutzomyia (Ps.) davisi (10, 10%), 5- Lutzomyia (N.) flaviscutellata (13, 13%) e outras oito espécies (20, 18%). Discussão: Espécies de Leishmania do subgênero Viannia, sobretudo L. (V.) braziliensis predominam em Juruti, o que é compatível com o extenso diâmetro das reações cutâneas observadas ao antígeno de Montenegro e com os relatos comuns de persistência e recidiva, apesar do tratamento específico. Entre os flebotomíneos antropófilos destacam-se L. (Ps.) complexa (17%) e L. (Ps.) flaviscutellata (13%) por serem vetores de L. (V.) braziliensis e L. (L.) amazonensis respectivamente, associadas às formas severas da LT humana. Conclusão: Medidas de controle em Juruti devem priorizar a redução da morbidade, diagnóstico precoce, busca ativa de LT humana, vigilância entomológica e de microambientes no entorno da área de impacto de mineração.
Resumo:
A Leishmaniose é uma doença causada pelo protozoário Leishmania sp, podendo acometer homem e animais dependendo da espécie do parasita, São transmitidos pelos flebotomíneos fêmeas, insetos do gênero Lutzomyia, que ao exercer o hematofagismo inoculam as formas promastigota infectantes, mas recentemente, tem sido levantado hipóteses sobre a transmissão por carrapatos. Segundo a vigilância epidemiológica de Imperatriz-MA a cidade é endêmica tanto para Leishmaniose Tegumentar (LT) quanto para a Leishmaniose Visceral (LV). Este trabalho teve como objetivo principal investigar a presença de DNA de Leishmania sp em carrapatos coletados de cães atendidos em petshop e Centro de Controle de Zoonoses do município de Imperatriz utilizando a técnica de PCR. O DNA foi extraído a partir de 640 carrapatos fêmeas e testadas utilizando o primer que amplifica o gene de mini-exon de Leishmania sp. Os carrapatos foram coletados de 41 cães de diferentes bairros da cidade de Imperatriz. A maioria dos carrapatos foram identificados como Rhipicephalus sanguineus. Os seguintes sinais clínicos sugestivos de leishmaniose foram observados nos cães: onicogrifose em 53,65% (22/41); úlceras em 63,41% (26/41), a perda de cabelo e inapetência em 39,02% (16/41). Cento e setenta carrapatos (26,56%) coletados de 16 cães apresentaram DNA de Leishmania do subgênero Viannia, responsável pela forma cutânea da doença. Não foi detectado nenhum DNA de Leishmania infantum chagasi. Carrapatos infectados foram coletados de ambos os cães sintomáticos e assintomáticos. Embora ainda não tenha sido demonstrado que os carrapatos possam transmitir Leishmania aos cães sob condições naturais, o resultado deste estudo tem vários aspectos importantes, pois é um método não-invasivo de detecção, capaz de diferenciar os grupos de parasitas em circulação, em especial se os animais não têm lesões, pode ser um indicador biológico em locais onde não é feito uma investigação sorológica e nem entomológica, podendo dar suporte aos programas de vigilância de saúde local.
Resumo:
A leishmaniose tegumentar americana (LTA) é uma doença infecciosa que atinge pele e mucosas e que vem apresentando um aumento significativo em sua incidência nas últimas décadas, tem uma prevalência global de aproximadamente 1,5 milhões de casos anuais em todo o mundo. O presente estudo tem uma abordagem analítica, descritiva, transversal, com objetivo de estabelecer perfil clínico epidemiológico e correlações etiológicas da leishmaniose tegumentar em uma série de casos na região oeste do Pará. Na pesquisa foram incluídos 102 indivíduos apresentando manifestações clínicas de LTA, selecionados no período de outubro de 2009 a novembro de 2011, atendidos no Centro de Controle de Zoonoses no município de Santarém, estado do Pará. As variáveis foram analisadas a partir da aplicação do teste qui-quadrado de aderência, e apresentadas através de figuras e tabelas. Os resultados demonstram que prevaleceram as infecções em indivíduos do sexo masculino 85,29%, na faixa etária de 30 a 40 anos 32,35%, trabalhadores e moradores da área rural que exercem ocupações na sua maioria de lavradores 21,57%, apresentaram lesões únicas 63,72%, do tipo ulceradas 77,45%, localizadas nos membros inferiores em 58,82% dos casos, com tempo de evolução da doença em média de 02 meses 74,50%. Conclusão: Seis espécies de Leishmania foram identificadas, sendo o subgênero Viannia mais prevalente e a espécie predominante a L (V). braziliensis.
Resumo:
Introduction Visceral leishmaniasis (VL) is caused by the intracellular protozoan Leishmania donovani complex. VL may be asymptomatic or progressive and is characterized by fever, anemia, weight loss and the enlargement of the spleen and liver. The nutritional status of the patients with VL is a major determinant of the progression, severity and mortality of the disease, as it affects the clinical progression of the disease. Changes in lipoproteins and plasma proteins may have major impacts in the host during infection. Thus, our goal was evaluate the serum total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides, glucose, albumin, globulin and total protein levels, as well as the body composition, of VL patients before and after treatment. Methods Nutritional evaluation was performed using the bioelectrical impedance analysis (BIA) to assess body composition. Biochemical data on the serum total cholesterol, HDL, LDL, triglycerides, glucose, albumin, globulin and total protein were collected from the medical charts of the patients. Results BIA indicated that both pre-treatment and post-treatment patients exhibited decreased phase angles compared to the controls, which is indicative of disease. Prior to treatment, the patients exhibited lower levels of total body water compared to the controls. Regarding the biochemical evaluation, patients with active VL exhibited lower levels of total cholesterol, HDL, LDL and albumin and higher triglyceride levels compared to patients after treatment and the controls. Treatment increased the levels of albumin and lipoproteins and decreased the triglyceride levels. Conclusions Our results suggest that patients with active VL present biochemical and nutritional changes that are reversed by treatment.